Добірка наукової літератури з теми "Fibroblast growth factor binding protein 1"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Fibroblast growth factor binding protein 1".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Fibroblast growth factor binding protein 1"
MIZUKOSHI, Eiichi, Masashi SUZUKI, Alexei LOUPATOV, Takehito URUNO, Hisaki HAYASHI, Tomoko MISONO, Sunil C. KAUL, Renu WADHWA, and Toru IMAMURA. "Fibroblast growth factor-1 interacts with the glucose-regulated protein GRP75/mortalin." Biochemical Journal 343, no. 2 (October 8, 1999): 461–66. http://dx.doi.org/10.1042/bj3430461.
Повний текст джерелаNewman, Andrew C., Martin N. Nakatsu, Wayne Chou, Paul D. Gershon, and Christopher C. W. Hughes. "The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation." Molecular Biology of the Cell 22, no. 20 (October 15, 2011): 3791–800. http://dx.doi.org/10.1091/mbc.e11-05-0393.
Повний текст джерелаDesnoyers, Luc, David Arnott, and Diane Pennica. "WISP-1 Binds to Decorin and Biglycan." Journal of Biological Chemistry 276, no. 50 (October 11, 2001): 47599–607. http://dx.doi.org/10.1074/jbc.m108339200.
Повний текст джерелаCarreras, Isabel, Celeste B. Rich, Julie A. Jaworski, Sandra J. Dicamillo, Mikhail P. Panchenko, Ronald Goldstein, and Judith Ann Foster. "Functional components of basic fibroblast growth factor signaling that inhibit lung elastin gene expression." American Journal of Physiology-Lung Cellular and Molecular Physiology 281, no. 4 (October 1, 2001): L766—L775. http://dx.doi.org/10.1152/ajplung.2001.281.4.l766.
Повний текст джерелаBriones, Victorino R., Shiyou Chen, Anna Tate Riegel та Robert J. Lechleider. "Mechanism of fibroblast growth factor-binding protein 1 repression by TGF-β". Biochemical and Biophysical Research Communications 345, № 2 (червень 2006): 595–601. http://dx.doi.org/10.1016/j.bbrc.2006.04.052.
Повний текст джерелаCaccia, P., O. Cletini, A. Isacchi, L. Bergonzoni, and G. Orsini. "Biochemical characterization of the molecular interaction between recombinant basic fibroblast growth factor and a recombinant soluble fibroblast growth factor receptor." Biochemical Journal 294, no. 3 (September 15, 1993): 639–44. http://dx.doi.org/10.1042/bj2940639.
Повний текст джерелаPrakash, S., and D. J. Wyler. "Fibroblast stimulation in schistosomiasis. XII. Identification of CD4+ lymphocytes within schistosomal egg granulomas as a source of an apparently novel fibroblast growth factor (FsF-1)." Journal of Immunology 148, no. 11 (June 1, 1992): 3583–87. http://dx.doi.org/10.4049/jimmunol.148.11.3583.
Повний текст джерелаTaipale, J., J. Saharinen, K. Hedman, and J. Keski-Oja. "Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils." Journal of Histochemistry & Cytochemistry 44, no. 8 (August 1996): 875–89. http://dx.doi.org/10.1177/44.8.8756760.
Повний текст джерелаFang, Xiaohong, Ewa K. Stachowiak, Star M. Dunham-Ems, Ilona Klejbor, and Michal K. Stachowiak. "Control of CREB-binding Protein Signaling by Nuclear Fibroblast Growth Factor Receptor-1." Journal of Biological Chemistry 280, no. 31 (May 31, 2005): 28451–62. http://dx.doi.org/10.1074/jbc.m504400200.
Повний текст джерелаShintani, Tomoaki, Mirai Higaki, and Tetsuji Okamoto. "Heparin-Binding Protein 17/Fibroblast Growth Factor-Binding Protein-1 Knockout Inhibits Proliferation and Induces Differentiation of Squamous Cell Carcinoma Cells." Cancers 13, no. 11 (May 29, 2021): 2684. http://dx.doi.org/10.3390/cancers13112684.
Повний текст джерелаДисертації з теми "Fibroblast growth factor binding protein 1"
Baker, Tabari M. "Regulation of microRNAs targeting the angiogenic switch molecule Fibroblast Growth Factor Binding Protein 1 by retinoic acid receptor activation." Thesis, Georgetown University, 2014. http://pqdtopen.proquest.com/#viewpdf?dispub=3618988.
Повний текст джерелаThis dissertation examines the role of retinoic acid receptor activation in the post-transcriptional regulation of a fibroblast growth factor binding protein. Previous work showed that all-trans retinoic acid (ATRA) reduces mRNA expression of the angiogenic switch molecule, Fibroblast Growth Factor Binding Protein 1 (FGFBP1 or FGF-BP), independent of an effect on transcription of the FGFBP1 mRNA. I hypothesized that a retinoid-induced microRNA was involved in FGFBP1 mRNA loss. MicroRNAs (miRs) are 19-22 nucleotide (nt) single stranded non-coding RNAs that post-transcriptionally repress mature mRNA function, thereby reducing expression of their target proteins. The current dogma suggests that miRs canonically bind to the 3' untranslated region (UTR) of mRNA through a 7-nt seed-matched site. However, recent data indicate that miRs may also bind the open reading frame (ORF) of mRNAs. In this dissertation, I show that miR-27b-3p and miR-125a-5p are induced by ATRA and target FGFBP1. Overexpression of miR-27b-3p and miR-125a-5p rapidly reduced FGFBP1 mRNA levels through a target site in the open reading frame of the FGFBP1 mRNA. Both microRNAs showed specificity for regions within the ORF of FGFBP1, suggesting that these microRNAs may also be involved in inhibiting translation of the FGFBP1 protein. Next generation sequencing data from The Cancer Genome Atlas shows that loss of these microRNAs is characteristic of several epithelial cancers, including head and neck, lung, and cervical squamous cell carcinomas, suggesting a tumor suppressor role for miRs 27a-3p and 125a-5p. In total, these data suggest an important regulatory role for miRs 27b-3p and 125a-5p in the oncogenesis of squamous cell carcinomas, through modulation of FGFBP1 expression.
Yateman, Martin Edward. "Regulation of human fibroblast insulin-like growth factor (IGF)-binding proteins by IGF-1 and cytokines, mechanisms of action and effects upon IGF bioactivity." Thesis, Queen Mary, University of London, 1995. http://qmro.qmul.ac.uk/xmlui/handle/123456789/1742.
Повний текст джерелаGillies, Peter John. "Modulation of dermal microvascular endithelial cell responses to growth factors and haemostatic factors in the presence of vitronectin." Thesis, Queensland University of Technology, 2008. https://eprints.qut.edu.au/37176/1/Peter_Gillies_Thesis.pdf.
Повний текст джерелаMontenegro, Luciana Ribeiro. "Estudo in vitro da sensibilidade ao IGF-1 de fibroblastos de crianças nascidas pequenas para a idade gestacional sem recuperação estatural pós-natal." Universidade de São Paulo, 2009. http://www.teses.usp.br/teses/disponiveis/5/5135/tde-08092009-132008/.
Повний текст джерелаIntroduction: Children born small for gestational age (SGA) have a higher risk of staying with short stature in adulthood. The insulin-like growth factors (IGF-1 and IGF-2) are the main endocrine factor determining fetal growth. Most of the known actions of IGFs are mediated by IGF-1R, a tyrosine kinase receptor. Recently, the IGF-1 insensitivity was identified causing growth retardation in children born SGA who who did not present spontaneous catch-up growth in postnatal life. Affected children had elevated IGF-1 and IGFBP-3 levels in addition to microcephaly. The role of post receptor defects in IGF-1 signaling on the deficit of growth is still unclear. Objective: To assess IGF-1 action and signaling in vitro in fibroblasts from SGA children. Methods: Fibroblasts cell cultures were developed from 2 controls (C1 and C2) and 4 patients with pre- and post-natal growth retardation (SGA1, SGA2, SGA3 and SGA4). IGF-1 insensitivity was demonstrated by severe pre and postnatal growth impairment without any evident cause, IGF1 SDS > 0 and poor growth response during high doses of hGH treatment. Three SGA patients presented microcephaly. Defects in the gene of the IGF1 and IGF1R were excluded by direct sequencing. One patient (SGA1) presents the Silver- Russell syndrome (SRS) with loss of methylation of the paternal allele in the ICR1 (imprinting center region 1) chromosome 11p15, important for IGF-2 expression. IGF-1 action was assessed by cell proliferation by colorimetric assay. IGF-1 signaling was assessed by AKT and ERK phosphorylation after IGF-1 stimulation through SDS-PAGE of intracellular extract followed by immunoblotting with specific antibodies. The expression of IGF1R and IGFBP3 gene was determined by Real-time quantitative PCR and the levels of the IGF-1R and IGBP-3 protein by direct immunoblotting. Results: The SGA1, SGA2 and SGA3 cell lines proliferated 31%, 60% and 78% less under IGF-1 stimulation in comparison of controls fibroblasts, respectively. The expression of IGF1R mRNA and the level of total amount of IGF-1R protein were similar in all SGA and control cell lines. Despite normal IGF-1R structure and quantity, the same 3 SGA cell lines that presented low proliferation response also had 50 to 85% lower ERK phosphorylation after IGF-1 treatment (p <0.001), although the similar total content of ERK1/2. In relation to PI3K pathway activation, all SGA cell cultures presented normal AKT phosphorilation. Fibroblasts from the SGA1 patient presented a 14x increase in IGFBP3 mRNA and 2x more IGFBP-3 secretion to culture serum medium. Treatment with desIGF-1, an IGF-1 analogue with low affinity for IGFBPs although retains its ability to activate the IGF-1R, did not recover cell proliferation or ERK phosphorylation. All cell lines presented similar amount of GRB10 protein Conclusion: Three of 4 SGA patients showed evidence of post-receptor IGF-1 insensitivity. The cell line SGA1, obtained from a SRS patient with ICR1 hypomethylation, showed increased expression and secretion of IGFBP-3, which was not directly responsible for inhibition in IGF- 1 action. Further studies should be developed to identify the molecular cause of IGF-1 post-receptor insensitivity observed in our patients.
Marshall, Nicholas John. "The influence of insulin-like growth factor 1 and its analogues on fibroblasts and dermal wound healing." Title page, table of contents and synopsis only, 1998. http://web4.library.adelaide.edu.au/theses/09MD/09mdm3685.pdf.
Повний текст джерелаMartin, Christopher School of Biomedical Engineering UNSW. "Investigation of exogenous growth factors; platelet derived growth factor, insulin-like growth factor binding protein and fibroblast growth factor, and their influence on in vivo bone repair." Awarded by:University of New South Wales. School of Biomedical Engineering, 2006. http://handle.unsw.edu.au/1959.4/30405.
Повний текст джерелаParipelly, Rammohan. "Molecular Level Interaction of Human Fibroblast Growth Factor-1 (hFGF-1) With Phloridzin." TopSCHOLAR®, 2013. http://digitalcommons.wku.edu/theses/1314.
Повний текст джерелаHamilton, Fairley. "Regulation of sex hormone binding globulin and insulin-like growth factor binding protein-1." Thesis, University College London (University of London), 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.243549.
Повний текст джерелаGeitgey, Delaney Kate. "Evaluating the role of fibroblast activation protein and fibroblast growth factor 21 in growth hormone-induced adipose tissue fibrosis." Ohio University Honors Tutorial College / OhioLINK, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=ouhonors1587596581428154.
Повний текст джерелаÖklü, Rahmi. "Expression of latent transforming growth factor-β1 binding protein-1 in atherosclerosis". Thesis, University of Cambridge, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.621723.
Повний текст джерелаКниги з теми "Fibroblast growth factor binding protein 1"
Westwood, Melissa. Biochemical characterisation of insulin-like growth factor binding protein-1. Manchester: University of Manchester, 1994.
Знайти повний текст джерелаC, Baxter R., Gluckman Peter D, and Rosenfeld Ron G, eds. The insulin-like growth factors and their regulatory proteins: Proceedings of the Third International Symposium on Insulin-Like Growth Factors, Sydney, 6-10 February 1994. Amsterdam: Excerpta Medica, 1994.
Знайти повний текст джерелаSun, John. The effects of insulin-like growth factor binding protein-1 on pre- and postnatal cardiac morphology and function. 2007.
Знайти повний текст джерелаBaxter, R. C., and Peter D. Gluckman. The Insulin-Like Growth Factors and Their Regulatory Proteins: Proceedings of the Third International Symposium on Insulin-Like Growth Factors, Sydn (International Congress Series). Elsevier Science Pub Co, 1994.
Знайти повний текст джерелаJohnston, Michael V. Coffin-Lowry Syndrome. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0057.
Повний текст джерелаЧастини книг з теми "Fibroblast growth factor binding protein 1"
Seth, John. "Insulin-Like Growth Factor Binding Protein-1." In The Immunoassay Kit Directory, 206. Dordrecht: Springer Netherlands, 1994. http://dx.doi.org/10.1007/978-94-011-1414-1_31.
Повний текст джерелаBidlingmaier, M. "Insulin-like growth factor binding protein-3." In Lexikon der Medizinischen Laboratoriumsdiagnostik, 1–2. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-49054-9_1585-1.
Повний текст джерелаMcKeehan, Wallace L., Mikio Kan, Jinzhao Hou, Fen Wang, Pamela Adams, and Per-Erik Mansson. "Heparin-Binding (Fibroblast) Growth Factor/Receptor Gene Expression in the Prostate." In Molecular and Cellular Biology of Prostate Cancer, 115–26. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3704-5_10.
Повний текст джерелаConover, Cheryl A., Jay T. Clarkson, Susan K. Durham, and Laurie K. Bale. "Cellular Actions of Insulin-Like Growth Factor Binding Protein-3." In Advances in Experimental Medicine and Biology, 255–66. Boston, MA: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4615-2988-0_25.
Повний текст джерелаLiu, Xiaozhen, Shuiliang Shi, Jun-Hui Chen, Dianqing Wu, Mikio Kan, Yoshiko Myoken, Tetsuji Okamoto, and J. Denry Sato. "Human Fibroblast Growth Factor-Binding Protein HBp17 Enhances the Tumorigenic Potential of Immortalized Squamous Epithelial Cells." In Animal Cell Technology: Basic & Applied Aspects, 343–52. Dordrecht: Springer Netherlands, 2002. http://dx.doi.org/10.1007/978-94-017-0728-2_61.
Повний текст джерелаBaxter, Robert C., and Janet L. Martin. "Regulation and Actions of Insulin-Like Growth Factor Binding Protein-3." In Advances in Experimental Medicine and Biology, 125–35. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4684-5949-4_12.
Повний текст джерелаCuevas, Pedro, Diana Reimers, Fernando Carceller, Fu Xiaobing, and Guillermo Giménez-Gallego. "Loss of Basic Fibroblast Growth Factor of Brain Ependyma in Old Spontaneously Hypertensive Rats." In Cell Signal Transduction, Second Messengers, and Protein Phosphorylation in Health and Disease, 161–67. Boston, MA: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4615-1879-2_16.
Повний текст джерелаDrescher, B., W. Zumkeller, H. Lauke, M. Hartmann, and M. S. Davidoff. "Insulin-Like Growth Factor-Binding Protein (IGFBP)-5 in Human Testicular Tubules." In Advances in Experimental Medicine and Biology, 153–54. Boston, MA: Springer US, 1997. http://dx.doi.org/10.1007/978-1-4615-5913-9_27.
Повний текст джерелаRechler, Matthew M., Alexandra L. Brown, Craig C. Orlowski, Yvonne W. H. Yang, Joyce A. Romanus, Lorenzo Chiariotti, and Carmelo B. Bruni. "Characterization and Cloning of a Rat Insulin-Like Growth Factor Binding Protein." In Molecular and Cellular Biology of Insulin-like Growth Factors and Their Receptors, 395–402. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4684-5685-1_33.
Повний текст джерелаClemmons, David R. "Insulin-Like Growth Factor Binding Protein Control Secretion and Mechanisms of Action." In Advances in Experimental Medicine and Biology, 113–23. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4684-5949-4_11.
Повний текст джерелаТези доповідей конференцій з теми "Fibroblast growth factor binding protein 1"
Baker, J. B., M. P. McGrogan, C. Simonsen, R. L. Gronke, and B. W. Festoff. "STRUCTURE AND PROPERTIES OF PROTEASE NEXIN I." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644765.
Повний текст джерелаBelin, D., D. Baccino, A. Wohlwend, A. Estreicher, J. Hurate, and J.-D. Vassalli. "A CELLULAR RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN ACTIVATOR." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1642957.
Повний текст джерелаZheng, H., Z. Zhou, and C. Chen. "Krupple-like factor 5 promotes breast cancer proliferation through activating fibroblast growth factor-binding protein transcription." In CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-4071.
Повний текст джерелаPatel, Nisha S., and Alisa Morss Clyne. "A Computational Model of Fibroblast Growth Factor-2 Binding to Isolated and Intact Cell Surface Receptors: Effects of Fibroblast Growth Factor-2 Concentration, Flow and Delivery Mode." In ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80798.
Повний текст джерелаLing, L., V. Nurcombe, A. Van Wijnen, and S. Cool. "PO-004 Antibodies targeting the heparin-binding domain of fibroblast growth factor receptor 1 for cancer therapy." In Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/esmoopen-2018-eacr25.541.
Повний текст джерелаRice, Megan S., Rulla M. Tamimi, James L. Connolly, Laura C. Collins, Dejun Shen, Michael N. Pollak, Bernard Rosner, Susan E. Hankinson, and Shelley S. Tworoger. "Abstract A68: Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and lobule type in the Nurses' Health Study II." In Abstracts: AACR International Conference on Frontiers in Cancer Prevention Research‐‐ Oct 22-25, 2011; Boston, MA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1940-6207.prev-11-a68.
Повний текст джерелаZhang, Liping, Andrzej Badzio, Theresa Boyle, Xian Lu, Rafal Dziadziuszko, Jacek Jassem, and Fred R. Hirsch. "Abstract 921: Fibroblast growth factor receptor 1 (FGFR1) protein expression and gene copy number in small cell lung cancer." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-921.
Повний текст джерелаIbrahim, YH, J. Hartel, K. La Parra, and D. Yee. "Insulin-like growth factor binding protein-1 (IGFBP-1) targets both the insulin-like growth factor (IGF) and integrin pathways for the inhibition of breast cancer cell motility." In CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-402.
Повний текст джерелаSaksela, O., D. Moscatelli, and D. B. Rifkin. "THE OPPOSING OF BASIC FIBROBLAST GROWTH FACTOR AND TRANSFORMING GROWTH FACTOR BETA ON THE REGULATION OF PLASMINOGEN ACTIVATOR ACTIVITY IN CAPILLARY ENDOTHELIAL CELLS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644660.
Повний текст джерелаPfaff, Liza E., Brian T. Kalet, Deanna D. Dailey, and Dawn L. Duval. "Abstract A23: Insulin-like growth factor 2 mRNA binding protein 1 (IGF2BP1) drives growth, metastasis and chemoresistance in human and canine osteosarcoma." In Abstracts: AACR Special Conference: The Translational Impact of Model Organisms in Cancer; November 5-8, 2013; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1557-3125.modorg-a23.
Повний текст джерелаЗвіти організацій з теми "Fibroblast growth factor binding protein 1"
Gibby, Krissa. Role of Fibroblast Growth Factor Binding Protein-1 in Mammary Development and Tumorigenesis. Fort Belvoir, VA: Defense Technical Information Center, October 2009. http://dx.doi.org/10.21236/ada525608.
Повний текст джерелаKagan, Benjamin L. Growth Factor Regulation of an Angiogenic Factor, the Fibroblast Growth Factor-Binding Protein (FGF-BP), in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, August 2001. http://dx.doi.org/10.21236/ada398106.
Повний текст джерелаKagan, Benjamin L. Growth Factor Regulation of an Angiogenic Factor, the Fibroblast Growth Factor-Binding Protein (FGF-BP), in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, August 2002. http://dx.doi.org/10.21236/ada410065.
Повний текст джерелаGross, Jennifer M. Insulin-Like Growth Factor Binding Protein-1 Interacts with Integrins to Inhibit Insulin-Like Growth Factor-Induced Breast Cancer Growth and Migration. Fort Belvoir, VA: Defense Technical Information Center, July 2003. http://dx.doi.org/10.21236/ada420347.
Повний текст джерелаFunkenstein, Bruria, and Shaojun (Jim) Du. Interactions Between the GH-IGF axis and Myostatin in Regulating Muscle Growth in Sparus aurata. United States Department of Agriculture, March 2009. http://dx.doi.org/10.32747/2009.7696530.bard.
Повний текст джерелаBarg, Rivka, Erich Grotewold, and Yechiam Salts. Regulation of Tomato Fruit Development by Interacting MYB Proteins. United States Department of Agriculture, January 2012. http://dx.doi.org/10.32747/2012.7592647.bard.
Повний текст джерелаHansen, Peter J., and Amir Arav. Embryo transfer as a tool for improving fertility of heat-stressed dairy cattle. United States Department of Agriculture, September 2007. http://dx.doi.org/10.32747/2007.7587730.bard.
Повний текст джерела